<DOC>
	<DOCNO>NCT00983164</DOCNO>
	<brief_summary>The objective present study evaluate antioxidant status blood HCV patient treat pegylated interferon ( 2a 1.5 ug/kg ; 2b 180 ug ) combine ribavirin ( 1000 1250 mg ) supplementation vitamin E , C mineral zinc ( 800 mg,500 mg 40 mg ; respectively ) six month .</brief_summary>
	<brief_title>Blood Antioxidant Status Chronic Hepatitis C Patients Before After Antioxidant Supplementation : Randomized Clinical Trial</brief_title>
	<detailed_description>The WHO estimate around 170 million people infected HCV , 3 % world population . HCV lead cause acute hepatitis chronic liver disease , may lead cirrhosis hepatocellular carcinoma . The combined therapy interferon without pegylation associate ribavirin show great sustained virological response monotherapy interferon-alpha , however response still represent around 60 % case . The mechanism HCV cause cellular damage yet well understood , however immune liver damage , direct cytotoxic damage mediate different viral product also oxidative stress implicate pathogenesis chronic hepatitis C. Several study support reactive oxygen specie ( ROS ) oxidative stress involve pathogenesis hepatitis C , despite increase ROS level HCV patient might beneficial suppress HCV replication . ROS involve several disease cause oxidative damage lipid , DNA , proteins carbohydrate .</detailed_description>
	<mesh_term>Hepatitis</mesh_term>
	<mesh_term>Hepatitis A</mesh_term>
	<mesh_term>Hepatitis C</mesh_term>
	<mesh_term>Hepatitis , Chronic</mesh_term>
	<mesh_term>Hepatitis C , Chronic</mesh_term>
	<mesh_term>Antioxidants</mesh_term>
	<criteria>without presence illness associate systemic disease , chronic alcoholism , without HIV coinfection , participate study . Patients hepatitis C select accord Clinical Protocol Guidelines Therapeutic Hepatitis C Viral . Group I All subject negative HCV , HBV , HIV , HBsAg , antiHBc total , antiHCV normal serum transaminase . Patients one follow laboratory abnormality also exclude : leukocyte , neutrophil , platelet , serum creatinine 1.5 time upper limit normal , elevated thyroid stimulate hormone , alphafetoprotein normal limit , and/or focal lesion ultrasound perform within 1 month study entry .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>antiviral therapy</keyword>
	<keyword>antioxidant therapy</keyword>
	<keyword>hepatitis C virus</keyword>
	<keyword>oxidative stress</keyword>
	<keyword>vitamin E</keyword>
</DOC>